Dlaboratory Sweden AB (publ) (DLAB.ST)
SEK 2.57
(-3.38%)
SEK 2.57
(-3.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.93 Million | -13.15 Million | -12.8 Million | -9.45 Million | -9.91 Million | - |
| Net Income | -11.05 Million | -9.11 Million | -15.43 Million | -13.61 Million | -8.15 Million | -7.11 Million |
| Depreciation & Amortization | 2.57 Million | 2.96 Million | 1.82 Million | 730 Thousand | 14.05 Thousand | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.47 Million | -7.25 Million | 2.54 Million | 3.43 Million | -2.27 Million | - |
| Other non-cash items | 1.07 Million | 256 Thousand | -1.73 Million | 3000.00 | 502.38 Thousand | 7.11 Million |
| Investing Cash Flow | - | - | -11.96 Million | - | -1.59 Million | - |
| Investments in PPE | - | - | -185 Thousand | - | - | - |
| Acquisitions | - | - | -11.77 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 405 Thousand | - | -1.59 Million | - |
| Financing Cash Flow | -248 Thousand | -303 Thousand | 45.73 Million | 13.37 Million | 13.93 Million | - |
| Debt repayment | -440 Thousand | -647 Thousand | -980 Thousand | -690 Thousand | -1.5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 192 Thousand | 344 Thousand | 52.12 Million | 14.06 Million | - | - |
| Other Financing Activities | 192 Thousand | -303 Thousand | -5.41 Million | 13.37 Million | 12.43 Million | - |
| Accounts receivables | -4000.00 | -5.55 Million | -4.13 Million | 3.25 Million | -2.4 Million | - |
| Accounts payables | 3.94 Million | -802 Thousand | 7.18 Million | -3.25 Million | - | - |
| Inventory | -474 Thousand | -896 Thousand | -501 Thousand | 123 Thousand | 120.51 Thousand | - |
| Other working capital | 3.94 Million | -802 Thousand | 7.18 Million | 3.31 Million | 11.27 Thousand | - |
| Cash at beginning of period | 14.71 Million | 28.16 Million | 7.19 Million | 3.26 Million | 839.06 Thousand | - |
| Cash at end of period | 10.53 Million | 14.71 Million | 28.16 Million | 7.19 Million | 3.26 Million | - |
| Capital Expenditure | - | - | -185 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | 839.06 Thousand | - |
| Net cash flow / Change in cash | -4.18 Million | -13.45 Million | 20.96 Million | 3.92 Million | 2.42 Million | - |
| Free Cash Flow | -3.93 Million | -13.15 Million | -12.98 Million | -9.45 Million | -9.91 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.77 Million | -4.11 Million | -1.7 Million | -11.05 Million | -122 Thousand | -2.93 Million |
| Depreciation & Amortization | 724 Thousand | 724 Thousand | 723 Thousand | 2.57 Million | 724 Thousand | 724 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.67 Million | 7.23 Million | -2.41 Million | 3.47 Million | 372 Thousand | -1.91 Million |
| Other non-cash items | 5.11 Million | -5.62 Million | 1.91 Million | 1.07 Million | -100 Thousand | -209 Thousand |
| Investing Cash Flow | -324 Thousand | -324 Thousand | - | - | - | - |
| Investments in PPE | -324 Thousand | -324 Thousand | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -324 Thousand | -324 Thousand | - | - | - | - |
| Financing Cash Flow | -120 Thousand | -120 Thousand | -71 Thousand | -248 Thousand | 63 Thousand | -120 Thousand |
| Debt repayment | -120 Thousand | -120 Thousand | -80 Thousand | -440 Thousand | -120 Thousand | -120 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 9000.00 | 192 Thousand | 183 Thousand | - |
| Other Financing Activities | - | - | 9000.00 | 192 Thousand | 183 Thousand | -120 Thousand |
| Accounts receivables | -3.9 Million | 5.28 Million | -349 Thousand | -4000.00 | -1.16 Million | -3.52 Million |
| Accounts payables | -76 Thousand | 1.67 Million | -3.14 Million | 3.94 Million | 1.27 Million | 2.67 Million |
| Inventory | 312 Thousand | 274 Thousand | 1.08 Million | -474 Thousand | 265 Thousand | -1.06 Million |
| Other working capital | -76 Thousand | 1.67 Million | -3.14 Million | 3.94 Million | 1.27 Million | 2.67 Million |
| Cash at beginning of period | 14.09 Million | 10.53 Million | 12.08 Million | 14.71 Million | 11.14 Million | 15.6 Million |
| Cash at end of period | 8.92 Million | 14.09 Million | 10.53 Million | 10.53 Million | 12.08 Million | 11.14 Million |
| Capital Expenditure | -324 Thousand | -324 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.16 Million | 3.56 Million | -1.55 Million | -4.18 Million | 937 Thousand | -4.45 Million |
| Free Cash Flow | -5.04 Million | 3.68 Million | -1.48 Million | -3.93 Million | 874 Thousand | -4.33 Million |
JM
SANGAMIND
APG
KAKEL
BXXRF
060720